Literature DB >> 7625737

Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect?

S Shariff1, C E Cumming, A Lees, M Handman, D C Cumming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7625737     DOI： 10.1111/j.1749-6632.1995.tb31394.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

2.  Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor [beta] knockout mice.

Authors:  Carolyn J Koonce; Alicia A Walf; Cheryl A Frye
Journal:  Neuroreport       Date:  2009-08-05       Impact factor: 1.837

3.  Suicidality and Illness Course Worsening in a Male Patient with Bipolar Disorder during Tamoxifen Treatment for ER+/HER2+ Breast Cancer.

Authors:  Claudia Carmassi; Francesco Pardini; Valerio Dell'Oste; Annalisa Cordone; Virginia Pedrinelli; Marly Simoncini; Liliana Dell'Osso
Journal:  Case Rep Psychiatry       Date:  2021-03-24

4.  Risk of developing depression from endocrine treatment: A nationwide cohort study of women administered treatment for breast cancer in South Korea.

Authors:  Jooyoung Oh; Hye Sun Lee; Soyoung Jeon; Dooreh Kim; Jeong-Ho Seok; Woo-Chan Park; Jae-Jin Kim; Chang Ik Yoon
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

5.  GABA+ levels in postmenopausal women with mild-to-moderate depression: A preliminary study.

Authors:  Zhensong Wang; Aiying Zhang; Bin Zhao; Jie Gan; Guangbin Wang; Fei Gao; Bo Liu; Tao Gong; Wen Liu; Richard A E Edden
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.